MedPath

Preoperative Biliary Drainage for Resectable Hilar Cholangiocarcinoma

Phase 4
Conditions
Cholangiocarcinoma
Drainage
Surgery
Interventions
Procedure: Preoperative biliary drainage
Registration Number
NCT00797121
Lead Sponsor
Sun Yat-sen University
Brief Summary

This study is to investigate whether preoperative biliary drainage can reduce the postoperative morbidity in patients with hilar cholangiocarcinoma.

Detailed Description

Preoperative biliary drainage(PBD) or not, is a Hot Spot issue in the management of Hilar cholangiocarcinoma. Surgeons from Japan tend to perform PTBD(Percutaneous Transhepatic Biliary Drainage) before a definite operation until the total bilirubin(TB) lower than 85μmol/L. For some patients needed to perform extended curative resection, PVE(Portal Vein Embolization) is performed and thus the duration of PBD may be around six weeks and the final TB is lower than 34μmol/L. Some tend to perform a definite curative operation in a short time after diagnosis. There is no RCT research on the effect of PBD for the resectable Hilar Cholangiocarcinoma patients to date.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
82
Inclusion Criteria
  • Patients newly diagnosed
  • Resectable patients after imaging assessment and evaluation of general condition of the patient
  • TB>85μmol/L
  • WBC account more than 1.5×109/L, PLT account more than 100×109/L and HB account more than 100g/L
  • No serious disease in heart, lung and kidney
  • Written informed consent
Exclusion Criteria
  • Unresectable patients.
  • Patients have received biliary drainage procedure such as PTBD before admission
  • Complicated with chronic hepatitis
  • Myocardia infarction record within six months
  • Women in pregnancy
  • Serious disease in heart, lung or kidney

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Preoperative biliary drainagePreoperative biliary drainage-
Primary Outcome Measures
NameTimeMethod
Incidence of postoperative complication30 days after operation
Secondary Outcome Measures
NameTimeMethod
Postoperative mortality30 days after operation
Overall survival, OSMay, 2013
Disease free survival, DFSMay, 2013

Trial Locations

Locations (1)

Department of Hepatobiliary, the first affiliated hospital, Sun Yat-sen University

🇨🇳

Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath